Item request has been placed!
×
Item request cannot be made.
×

Processing Request
Item request has been placed!
×
Item request cannot be made.
×

Processing Request
-
Authors :
Huang L; Phase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.; Lei J
Subjects: Lamivudine*; Adult ; Humans
-
Source:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Jan; Vol. 13 (1), pp. 70-76. Date of Electronic Publication: 2023 Jul 20.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
تفاصيل العنوان
-
Source:
Hepatitis Monthly. Dec2023, Vol. 23 Issue 1, p1-10. 10p.
تفاصيل العنوان
-
Source:
Alimentary Pharmacology & Therapeutics. Nov2021, Vol. 54 Issue 9, p1134-1149. 16p. 1 Diagram, 6 Charts, 2 Graphs.
تفاصيل العنوان
-
Authors :
Jing C; Division of Infectious Diseases, the First Hospital of Changsha, Changsha, Hunan, China.; Wei T
Subjects: HIV-1* ; HIV Infections*; Humans
-
Source:
BMC infectious diseases [BMC Infect Dis] 2023 Jun 12; Vol. 23 (1), pp. 396. Date of Electronic Publication: 2023 Jun 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334
تفاصيل العنوان
-
Source:
BMC Infectious Diseases. 6/6/2024, Vol. 24 Issue 1, p1-9. 9p.
تفاصيل العنوان
-
Source:
Journal of Viral Hepatitis. Apr2021, Vol. 28 Issue 4, p592-600. 9p.
تفاصيل العنوان
-
Source:
Infectious Diseases & Therapy. Nov2023, Vol. 12 Issue 11, p2581-2593. 13p.
تفاصيل العنوان
-
Authors :
Wang Z; National Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical University, No 155, Nanjing North Street, Heping District, Shenyang, 110001, Liaoning Province, China.; Key Laboratory of AIDS Immunology, Chinese Academy of Medical Sciences, Shenyang, 110001, China.
Subjects: Drug Resistance, Viral*/Drug Resistance, Viral*/Drug Resistance, Viral*/genetics; Anti-HIV Agents/Anti-HIV Agents/Anti-HIV Agents/*therapeutic use ; Emtricitabine/Emtricitabine/Emtricitabine/*therapeutic use
-
Source:
BMC infectious diseases [BMC Infect Dis] 2021 Jul 09; Vol. 21 (1), pp. 668. Date of Electronic Publication: 2021 Jul 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334
تفاصيل العنوان